275 related articles for article (PubMed ID: 26870717)
21. Pathologic fractures in bisphosphonate-related osteonecrosis of the jaw-review of the literature and review of our own cases.
Otto S; Pautke C; Hafner S; Hesse R; Reichardt LF; Mast G; Ehrenfeld M; Cornelius CP
Craniomaxillofac Trauma Reconstr; 2013 Sep; 6(3):147-54. PubMed ID: 24436752
[TBL] [Abstract][Full Text] [Related]
22. [A case of bisphosphonate-related osteonecrosis of the jaw in a patient who had received intravenous bisphosphonates].
Ishikawa T
Gan To Kagaku Ryoho; 2014 Feb; 41(2):225-7. PubMed ID: 24743202
[TBL] [Abstract][Full Text] [Related]
23. Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC).
Thomas C; Spanidis M; Engel C; Roos FC; Frees S; Neisius A; Hampel C; Rubenwolf P; Thüroff JW; Walter C; Miederer M
Clin Oral Investig; 2016 May; 20(4):753-8. PubMed ID: 26307268
[TBL] [Abstract][Full Text] [Related]
24. Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction.
Bodem JP; Kargus S; Eckstein S; Saure D; Engel M; Hoffmann J; Freudlsperger C
J Craniomaxillofac Surg; 2015 May; 43(4):510-4. PubMed ID: 25841311
[TBL] [Abstract][Full Text] [Related]
25. Multipotent mesenchymal stromal cell sheet therapy for bisphosphonate-related osteonecrosis of the jaw in a rat model.
Kaibuchi N; Iwata T; Yamato M; Okano T; Ando T
Acta Biomater; 2016 Sep; 42():400-410. PubMed ID: 27326918
[TBL] [Abstract][Full Text] [Related]
26. [Clinical features of osteonecrosis of jaws after bisphosphonates therapy for bone metastasis of breast cancer].
Guo YX; Wang DC; Wang Y; Peng X; Mao C; Guo CB
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):80-3. PubMed ID: 26885913
[TBL] [Abstract][Full Text] [Related]
27. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment.
Kwon TG; Lee CO; Park JW; Choi SY; Rijal G; Shin HI
Clin Oral Implants Res; 2014 May; 25(5):632-40. PubMed ID: 23278625
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of the early stages of intravenous bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.
Matsuo A; Hamada H; Kaise H; Chikazu D; Yamada K; Kohno N
Acta Odontol Scand; 2014 Nov; 72(8):656-63. PubMed ID: 24521290
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology, pharmacology and clinical characterization of bisphosphonate-related osteonecrosis of the jaw. A retrospective study of 70 cases.
Pelaz A; Junquera L; Gallego L; García-Consuegra L; García-Martínez L; Cutilli T; Olay S
Acta Otorrinolaringol Esp; 2015; 66(3):139-47. PubMed ID: 25308796
[TBL] [Abstract][Full Text] [Related]
30. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.
Hokugo A; Kanayama K; Sun S; Morinaga K; Sun Y; Wu Q; Sasaki H; Okawa H; Evans C; Ebetino FH; Lundy MW; Sadrerafi K; McKenna CE; Nishimura I
Bone; 2019 Jun; 123():115-128. PubMed ID: 30926440
[TBL] [Abstract][Full Text] [Related]
31. Accurate approach in the treatment of oral bisphosphonate-related jaw osteonecrosis.
de Souza Faloni AP; Queiroz TP; Comelli Lia RC; Cerri PS; Margonar R; Rastelli AN; Marcantonio E
J Craniofac Surg; 2011 Nov; 22(6):2185-90. PubMed ID: 22075816
[TBL] [Abstract][Full Text] [Related]
32. Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study.
Pautke C; Bauer F; Otto S; Tischer T; Steiner T; Weitz J; Kreutzer K; Hohlweg-Majert B; Wolff KD; Hafner S; Mast G; Ehrenfeld M; Stürzenbaum SR; Kolk A
J Oral Maxillofac Surg; 2011 Jan; 69(1):84-91. PubMed ID: 20971542
[TBL] [Abstract][Full Text] [Related]
33. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.
Del Fabbro M; Gallesio G; Mozzati M
Eur J Cancer; 2015 Jan; 51(1):62-74. PubMed ID: 25466505
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of bisphosphonate-related osteonecrosis of the jaw after kidney transplantation.
Park W; Lee SH; Park KR; Rho SH; Chung WY; Kim HJ
J Craniofac Surg; 2012 Sep; 23(5):e510-4. PubMed ID: 22976726
[TBL] [Abstract][Full Text] [Related]
35. Clinical experience with spiramycin in bisphosphonate-associated osteonecrosis of the jaw.
Gasparini G; Saponaro G; Di Nardo F; Moro A; Boniello R; Cervelli D; Marianetti TM; Palazzoni G; Pelo S
Int J Immunopathol Pharmacol; 2010; 23(2):619-26. PubMed ID: 20646357
[TBL] [Abstract][Full Text] [Related]
36. [Risk assessment of bisphosphonate-related osteonecrosis of the jaw based on CBCT scans].
Koppány F; Joób-Fancsaly Á; Németh Z; Belik AA; Vaszilkó M; Varmuzsa EM; Csomó KB
Orv Hetil; 2020 May; 161(21):867-872. PubMed ID: 32427571
[TBL] [Abstract][Full Text] [Related]
37. Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.
Shudo A; Kishimoto H; Takaoka K; Noguchi K
Osteoporos Int; 2018 Oct; 29(10):2315-2321. PubMed ID: 29967931
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of dental implants as a risk factor for the development of bisphosphonate-related osteonecrosis of the jaw in breast cancer patients.
Matsuo A; Hamada H; Takahashi H; Okamoto A; Kaise H; Chikazu D
Odontology; 2016 Sep; 104(3):363-71. PubMed ID: 25956267
[TBL] [Abstract][Full Text] [Related]
39. [Bisphosphonate-associated osteonecrosis of the jaw].
Koy S; Schubert M; Koy J; Ney M; Lauer G; Sabatowski R
Schmerz; 2015 Apr; 29(2):171-8. PubMed ID: 25860198
[TBL] [Abstract][Full Text] [Related]
40. Clinical treatment outcomes for 40 patients with bisphosphonates-related osteonecrosis of the jaws.
Lee LW; Hsiao SH; Chen LK
J Formos Med Assoc; 2014 Mar; 113(3):166-72. PubMed ID: 24630034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
